1.
J Cell Commun Signal
; 16(1): 1-3, 2022 Mar.
Article
in English
| MEDLINE
| ID: mdl-34076828
ABSTRACT
The pathophysiology of COVID-19 is an enigma with its severity often determined by the extent of coagulopathy. Several regulatory pathways targeted by the SARS-CoV-2 include the renin-angiotensin system, von Willebrand Factor, and most importantly, the complement pathway. This article discusses these pathways to help design potential future therapies.